Posaconazole-induced hypertension in children with cystic fibrosis

Posaconazole is a triazole antifungal with a broad spectrum of activity against moulds including Aspergillus spp. Emerging data suggest posaconazole may be effective in the treatment of allergic bronchopulmonary aspergillosis complicating cystic fibrosis.

Citation:
Marpole R, Yeoh DK, Withers AL. Posaconazole-induced hypertension in children with cystic fibrosis. Respirology Case Rep. 2021;9(9).

Keywords:
Allergic bronchopulmonary aspergillosis; cystic fibrosis; hypertension; posaconazole

Abstract:
Posaconazole is a triazole antifungal with a broad spectrum of activity against moulds including Aspergillus spp. Emerging data suggest posaconazole may be effective in the treatment of allergic bronchopulmonary aspergillosis complicating cystic fibrosis.